期刊名称：HEPATOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and Scope
The premier publication in the field of liver disease, Hepatology publishes original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism.
Keywords
Hepatology, Hepatitis, Cirrhosis, Liver, Gastroenterology, Immunology
Abstracting and Indexing Information
- Abstracts in Anthropology (Baywood Publishing)
- Biological Abstracts® (Thomson ISI)
- BIOSIS Previews® (Thomson ISI)
- CAB HEALTH (CABI)
- CABDirect (CABI)
- CAS: Chemical Abstracts Services ()
- Chemical Abstracts Service/SciFinder (ACS)
- Current Awareness in Biological Sciences (Elsevier)
- Current Contents®/Clinical Medicine (Thomson ISI)
- Current Contents®/Life Sciences (Thomson ISI)
- EMBASE/Excerpta Medica (Elsevier)
- ETOH (National Institute on Alcohol Abuse and Alcoholism)
- IBIDS: International Bibliographic Information on Dietary Supplements ()
- Index Medicus/MEDLINE/PubMed (NLM)
- International Pharmaceutical Abstracts (Thomson Scientific)
- Journal Citation Reports/Science Edition (Thomson ISI)
- MEDLINE/PubMed (NLM)
- Reference Update (Thomson ISI)
- Science Citation Index Expanded™ (Thomson ISI)
- Science Citation Index® (Thomson ISI)
- SCOPUS (Elsevier)
- SIIC Databases (Sociedad Iberoamericana de Informacion Cientifica)
- Web of Science® (Thomson ISI)
Instructions to Authors
For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.
Author Guidelines
HEPATOLOGY publishes original research on the biology and diseases of the liver in both humans and experimental models.
Manuscripts should be sent with a cover letter to:
Keith D. Lindor
Editor, HEPATOLOGY
1001 Fairfax Street, Ste. 400
Alexandria, VA 22314-1503
Telephone: 703-299-9766
Fax: 703-299-9676
E-mail: hepatology@aasld.org
To submit your manuscript electronically and for complete instructions on how to do so, go to http://mc.manuscriptcentral.com/hep .
Please note: This journal does not accept Microsoft Word 2007 documents at this time. Please use WORD's "Save As" option to save your document to an older (.doc) file type.
Types of Manuscripts
The Editors will consider and publish the following:
Manuscripts describing original research must be no longer than 5,000 words (including references), abstract of 275 words, and a title with no more than 120 characters (excluding spaces).
Rapid Communications are brief, definitive reports of unusual interest, justifying expedited review, and should be no longer than 3,000 words ( including references). A paper submitted as a rapid communication should be identified as such in the cover letter. It will undergo expedited peer review and will be published within 2 months of acceptance. Manuscripts submitted for rapid communication will be accepted or rejected at the initial disposition stage. Any revision to an accepted rapid communication must be stylistic and very minor. A rapid communication rejected at the initial disposition stage may be resubmitted for a full review.
Concise Reviews of both basic and clinical topics should be no longer than 5,000 words (including references). The reference list need not be exhaustive. While most reviews are invited by the Editors, authors interested in contributing reviews are requested to first contact the Editor or one of the Associate Editors with an outline of the proposed article.
Letters to the Editor may be subjected to peer review and undergo editing for clarity and brevity, and should be no longer than 500 words and include no more than 10 references and one figure.
Editorials are invited by the Editor or Associate Editors and should be no longer than 1,500 words.
HEPATOLOGY Elsewhere should be no longer than 1,500 words and are invited by an Associate Editor. Suggestions for this type of manuscript should be made to the Editor or an Associate Editor (see the Editorial Board for appropriate Associate Editors). Permission from the publisher and author for the abstract to be reprinted should be included.
Image of the Month section is designed to highlight interesting liver pathological and radiographic findings along with their clinical correlation and relevance. Submissions should be limited to no more than 500 words and include high-quality gross photos and/or histomicrograph(s) or imaging studies. These should include a brief clinical history, detailed description of the image(s), the differential diagnosis, and three to five pertinent references. The number of authors should be limited to two, with ideally one author being a pathologist or radiologist.
Special Articles are on a variety of topics and may include AASLD practice guidelines, in-depth scientific reviews, meeting reports, and comments on social policy. The length of each article is decided by the Editor on a case-by-case basis.
Manuscripts that exceed the word limits listed above will be returned to the authors for shortening without a full review. Manuscripts that are redundant or contain extraneous material will be returned after a full review for shortening even if otherwise acceptable.
Submission Elements
Submissions must include the following:
- Complete manuscript (title page, author information, anstract, and text) as one Microsoft Word document
- Tables submitted separately in one Microsoft Word document
- Figures submitted separately in TIFF format with a resolution of 300 dpi (dots per inch)
- No more than 8 figures and tables, with a maximum of 6 panels per figure. We encourage you to submit non-essential figures or portions of your manuscript as supplementary material for online publication only
- Any material that could constitute prior or concurrent publication of similar data by any of the authors, including symposium proceedings, book chapters, invited papers, and the like
- The names of reviewers whose expertise qualifies them to review the work
- A description of any commercial affiliation or consultancy of an author that could be construed as a conflict of interest (this information will be kept confidential unless the Editor recommends disclosure in a footnote if an appearance of a conflict is perceived)
- An author agreement signed by every contributing author. It is assumed, however, that the corresponding author speaks for his or her coauthors and certifies that all listed authors participated meaningfully in the study and that they have seen and approved the final manuscript.
- Editorial formatting (use of italics, superscripts, Greek letter, etc.) should be consistent. Typographical formatting (column widths, type styles, etc.) should not be used. Text should be flush left; paragraphs should not be indented and should be separated by two hard returns. Do not use hard returns within paragraphs. Do not use the program's indenting or margin-setting features; these will be added during typesetting.
- Submissions may include the names of any reviewers the authors wish to exclude along with the reason for exclusion for the Editors to consider.
Manuscript Organization
All elements of a manuscript should be double-spaced, and all pages must be numbered in the upper right corner, starting with the title page. Manuscripts describing original research should contain, in this order, the following elements:
TITLE PAGE
Title
No more than 120 characters, not including spaces between words. The use of acronyms and abbreviations should be avoided. The species used for work with experimental animals must be indicated in the title.
Author Names
The full name, e-mail, and institutional affiliation of all authors must be included. In a multi-authored work involving more than a single institution, indicate individual affiliation by means of a superscript Arabic number. Indicate a change of address similarly.
Keywords
Five keywords that do not appear in the title itself.
FOOTNOTE PAGE
Contact Information
Name, address, telephone number, fax number, and e-mail address for author to whom proofs should be sent.
List of Abbreviations
Include the expansions and list in the order of their mention in the paper.
Financial Support
List grants and other financial support.
ABSTRACT
Write as continuous text organized as background and rationale for the study, main results, and conclusions. Acronyms and abbreviations must be defined in the abstract to allow the abstract to stand alone. Do not exceed 275 words. The last section should start with Conclusion:
INTRODUCTORY STATEMENT
Do not include a heading. Provide the minimum background information that will orient the general reader.
EXPERIMENTAL PROCEDURES
Provide a level of detail such that another investigator could repeat the work; for methods that are used without significant modification, citation of the original work will suffice.
Human Subjects
For reports of research using human subjects, provide assurance that (a) informed consent in writing was obtained from each patient and (b) the study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the appropriate institutional review committee. Refer to individual patients by number, not by initials. HEPATOLOGY will only accept papers for review from liver transplant centers that explicitly state that no donor organs were obtained from executed prisoners or other institutionalized persons. Papers without such explicit statements will be returned without review.
Animal Experimentation
In studies involving animal experimentation, provide assurance that all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985).
Genetic Sequence Data
In papers reporting a novel DNA or amino acid sequence, verify that the data have been or will be submitted either to GenBank or EMBL, and provide the accession number. This information need not accompany the initially submitted manuscript but must be available for inclusion in the final publication. Accession numbers appear as footnotes to the text or in the relevant figure legend. It is understood that authors publishing in HEPATOLOGY will make cloned DNA, hybridomas, mutant animals, and other resources available to qualified investigators. Raw data submitted with a manuscript may only be electronically published and available to HEPATOLOGY readers at the Journal's Web site.
Manufacturers
Include the names and locations (city and state or country) of manufacturers when mentioning proprietary drugs, tools, instruments, software, etc.
CLINICAL TRIALS
Randomized controlled trials should be presented according to the CONSORT guidelines (JAMA 2001;285:1987-1991 or http://www.consort-statement.org ). Authors must provide the CONSORT checklist (found at http://mc.manuscriptcentral.com/hep , under Instructions and Forms) with a diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. Manuscripts that fail to comply with CONSORT guidelines or do not include the CONSORT checklist at the time of submission will not be reviewed for publication.
All clinical trials should be registered in order to be published in HEPATOLOGY. RESULTS AND DISCUSSION
These two sections must be separate. Present the major findings of thestudy in graphicform if practicable. Do not illustrate minor details if theirmessage is conveyedadequately by simple descriptive text. Mention all tablesand figures. In thediscussion, concisely present the implications of the newfindings for the fieldas a whole, minimizing reiteration of the results,avoiding repetition of materialin the introduction, and keeping a close focuson the specific topic of thepaper.
REFERENCES
Number references in the order cited as Arabic numerals in parentheseson theline. Only literature that is published or in press (with the name ofthe publicationknown) may be numbered and listed; abstracts and letters to theeditor may becited, but they must be less than 3 years old and identified assuch. Referto only in the text, in parentheses, other material (manuscriptssubmitted,unpublished data, personal communications, and the like) as in thefollowingexample: (Chercheur X, unpublished data). If the owner of theunpublished dataor personal communication is not an author of the manuscriptunder review, asigned statement is required verifying the accuracy of theattributed informationand agreement to its publication.
Use Index Medicus as the style guide for references and other journalabbreviations.List all authors up to six, using six and "et al." when thenumberis greater than six.
EndNote is a software product that we recommend to our journal authorsto help simplify and streamline the research process.
Download Reference Style for HEPATOLOGY: If you already use EndNote, you can download the reference style for this journal.
How to Order: To learn more about EndNote, or to purchase your own copy, go to the following URL: www.interscience.wiley.com/jendnotes *.
Technical Support: If you need assistance using EndNote, contact endnote@isiresearchsoft.com , or visit www.endnote.com/support .
Journal Articles
1. Crawley AC, Brook DA, Muller VJ, Petersen BA, Isaas EL, BiekickiJ,et al. Enzyme replacement therapy in feline model of theMatroteaux-Lamysyndrome. J Clin Invest 1996;97:1864-1873.
Books
2. Watson JD. The Double Helix. New York: Atheneum, 1968:1-6.
Book Chapters
3. Hofmann AF. The enterohepatic circulation of bile acids in healthand disease.In: Sleisinger MH, Fordtran JS, eds. Gastrointestinal Disease.Volume 1. 5thed. Philadelphia: Saunders, 1993:127-150.
Abstract or Article in a Supplement
4. Klin M, Kaplowitz N. Differential susceptibility of hepatocytesto TNF-inducedapoptosis vs necrosis [Abstract]. HEPATOLOGY 1998;28(Suppl):310A.
TABLES
Prepare tables on individual sheets of paper, double-spaced, and numbered consecutively with Arabic numerals in the order of their appearance in the text. Do not duplicate material presented in a figure. Large tables submitted with a manuscript may only be electronically published and available to HEPATOLOGY readers at the Journal's Web site. Tables should read vertically when possible and should have headings for each column.
FIGURE LEGENDS
Number with Arabic numerals in the order mentioned in the text. Provide a title (this should not appear on the figure itself) and sufficient explanation to render the figure intelligible without reference to the text. Explain all abbreviations and symbols. For any copyrighted material, indicate that permission has been obtained (see Permissions, below). Type figure legends consecutively on a separate sheet of paper. If your figures include text, an 8 to 10 point font should be used. Acceptable fonts are "sans serif" fonts such as Arial, Helvetica, and Myriad. Examples of unacceptable fonts ("serif" fonts) are Times, Palatino, and Georgia. Lettering should begin with an upper case letter, followed by lower case lettering.
OTHER MANUSCRIPT ELEMENTS
Acknowledgment.
Acknowledge personal assistance and providers of special reagents. Note that grant and other financial support is listed on the footnote page, not here.
Permissions.
Direct quotations, tables, or illustrations taken from copyrighted material must be accompanied by written permission for their use from the publisher and the original author. A standard permission request form is included in this section. The permission is presented as a footnote or addition to the legend and must provide complete information as to source. Photographs of identifiable persons must be accompanied by a signed release that indicates informed consent.
Abbreviations.
Standard abbreviations not requiring definition can be found in the AMA Manual of Style. Do not abbreviate otherwise unless a term is used more than five times in the manuscript. In this case, the abbreviation should be spelled out, in parentheses, in its first use in the text and also listed on the footnote page (see above). Abbreviations used in figures or tables should be defined in the legend. Express temperatures as degrees Celsius and other measurements in SI units.
Drug Names.
Use generic names. The proprietary name may be mentioned in parentheses with the name and location (city and state or country) of the manufacturer.
FIGURES
Figures can be submitted to HEPATOLOGY two ways:
- Electronically, via the ScholarOne Manuscripts web site at http://mc.manuscriptcentral.com/hep
- By mailing high quality glossy prints:
HEPATOLOGY Editorial Office
1001 North Fairfax St., Ste. 400
Alexandria, VA 22314
Electronic Method (preferred)
All figures submitted for review need to be in TIFF (Tagged Image File Format) or EPS (Encapsulated Post-Script) format.
Figures that are line art (i.e. bar graphs, pie charts, etc.) need to have a resolution of at least 300 DPI (dots per inch) at full size with no compression. Figures that are black and white or color images (i.e. pictures of cells, etc.) need to have a resolution of at least 300 DPI at full size with no compression. Color figures should be in CMYK color mode and black and white figures should be set to Grayscale color mode.
Some figures may be converted from MS Word and PowerPoint format to TIFF format by following Instructions for converting MS Word and PowerPoint format to TIFF below
To ensure that your digital graphics are suitable for print purposes, please go to Rapid Inspector at http://rapidinspector.cadmus.com/RapidInspector/zwi/index.jsp . This free, stand-alone software application will help you to inspect and verify illustrations right on your computer.
Please note that authors are charged for color figures, the cost being $500 for each page that contains any color figures. Figures submitted in color for review will be published in color. The publisher will send and invoice for color charges directly to the corresponding author.
Instructions for converting MS Word and PowerPoint format to TIFF
- In MS Word or PowerPoint, choose file and print.
- Select PDF from the drop down menu.
- Click on Properties and select the Adobe PDF Settings.
- Select High Quality from the drop down menu.
- Make sure the following boxes are checked: view Adobe PDF results, prompt for Adobe PDF filename, add document information, do not send fonts to “Adobe PDF”, and delete log files of successful jobs.
- Click OK on the Adobe PDF Document Properties dialog box.
- Click OK on the Print dialog box.
- Save the file to your computer.
- The PDF will automatically open in Adobe Acrobat. Look over your figure and make sure everything looks right.
- If everything looks fine, follow these instructions:
- Open your PDF in Adobe Photoshop.
- In the Rasterize Generic PDF Format dialog box, change the resolution to the appropriate setting (300 Pixels/Inch for pictures).
- Please note that your figures are set at full size and the Mode is set accordingly— Grayscale for black and white figures and CMYK for color figures.
- Make sure the Anti-aliased and Constrain Proportions boxes are checked. Click OK to open.
- In the Layers Palette, click on the small triangle on the right to access the drop down menu (if the Layers Palette is not showing select the Windows menu and choose Layers).
- Select Flatten Image.
- Next, choose File and Save As.
- Choose TIFF format from the drop down menu and click the Save button.
- In the TIFF Options dialog box, choose none for the compression and IBM PC for the byte order.
Mail Method (optional).
The Journal requires one set of figures. Mark the back of eachfigurein pencil with the figure number, its orientation, and the name of thefirstauthor. Do not use paper clips, ink, or other handling that could damagethefigures. Large numbers of figures submitted may only be electronicallypublishedand available to HEPATOLOGY readers online. If a manuscriptisrejected, one set of glossy figures will be kept at the central office;allother figures will be returned to the authors.
Black and White.
Provide clean laser prints of black and white drawings andhigh-contrast glossy18-cm-wide photographs of all halftone figures, e.g.,photomicrographs,gels, etc. Manually typed or hand-written material is notacceptable.
Color.
Provide glossy prints in which lettering and symbols are clearlyvisible againstthe background. Authors are charged for color figures, the cost being $500 for each page that contains color. Figures submitted in color for review will be published in color. The publisher will send an invoicefor color charges directly to the corresponding author.
Digital Figures.
Hard copies of all artwork must accompany the digital files. Pleaseprovidedigital files on 3 1/2" diskette, 100-mb or 200-mb Iomega Zip disk, orCD-ROM.Scaling, cropping, and rotating should be performed in the originatingapplication.We recommend Adobe Photoshop for generating pixel-based graphicsand eitherAdobe Illustrator or Macromedia's Freehand for generatingvector-based graphics.Black and white (B/W) line art is either pixel based(typically generatedby scanning the image) or vector based (generated using adrawing program suchas Freehand or Illustrator ). Pixel-based artworkshould be supplied inTIFF format and at a resolution of not less than 300dotsper square inch(dpi). Vector-based artwork should be supplied as EPS files.B/W halftonesshould be supplied in TIFF format. The halftone should beprovided at theproper resolution. The finished resolution should be at least300 dpi. Colorartwork should be provided as an EPS or TIFF file. Files shouldbe convertedfrom RGB to CMYK. The finished resolution should be at least 300dpi.
Note that these file formats are not acceptable for printing: JPG, GIF,ONG,PCX, PNG, XBM, PDF, PPT, MS Word, and Excel. We recommend creating yourgraphics in Photoshop,Illustrator, or Freehand and importing them into yourpage applications as TIFFswith all fonts included. Do not scan figures asJPEGs and convert to TIFFs.
To ensure that your digital graphics are suitable for print purposes,please go to Rapid Inspector at http://rapidinspector.cadmus.com/RapidInspector/zwi/index.jsp .This free, stand-alone software application will help you to inspect andverify illustrations right on your computer.
Cover Photograph.
Authors with accepted manuscripts (or accepted pending minorrevision) may submitartwork for consideration for the cover. The material maybe different fromthe figures used in the article but should represent itscontent. Single slidesor color photographs are preferred, and multipleexamples may be submitted.Individual photographs should be trimmed to 21 × 28cm (width ×height) for production as is, and they should be accompanied by afour- to five-wordcaption and a two-sentence legend. Authors are not chargedfor a cover photograph.
PEER REVIEW AND PUBLISHING
The Journal uses anonymous peer review in evaluating manuscripts for publication. The Editor can choose to Early Reject a manuscript without peer review if the manuscript is incomplete or unlikely to be accepted. The Editor allows a single resubmission only after the initial disposition. A manuscript requiring more than a single revision or returned beyond 4 months of the date of the initial decision will be considered a new submission.
The Journal is published only in English. Authors lacking facility with English syntax should seek the appropriate assistance prior to submitting their manuscript.
Copyright of all material published in HEPATOLOGY is vested in the American Association for the Study of Liver Diseases. In accordance with the Copyright Act of 1976, a Copyright Assignment form (which follows these guidelines) signed by all authors must accompany all manuscripts. Statements and opinions expressed in the articles and communications in HEPATOLOGY are those of the author(s) and not necessarily those of the Editor(s) or publisher, and the Editor(s) and publisher disclaim any responsibility or liability for such material. Neither the Editor(s) nor the publisher guarantees, warrants, or endorses any product or service advertised in the Journal, nor do they guarantee any claim made by the manufacturer of such product or service. CONFLICT OF INTEREST
Please disclose all financial arrangements within the past two years,including consultancies, stock ownership, equity interest, patent-licensingagreements, research support, major honoraria, etc. you have with a companywhose product figures prominently in the manuscript you are submitting,sending a letter to the editor, or providing an editorial. Please provide thesame information for similar relationships with a company making a competingproduct to that which is featured in the manuscript. If the Editor finds thatsuch activities raise the appearance of a conflict, he may recommenddisclosure in a footnote. Otherwise, the information will remain confidential.
RESOURCES FOR AUTHORS
Editorial Board
E d i t o r
Keith D. Lindor
Rochester, MN
A s s o c i a t e E d i t o r s
Jordi Bruix
Barcelona, Spain
Elizabeth M. Brunt
St. Louis, MO
Michael R. Charlton
Rochester, MN
Gregory J. Gores
Rochester, MN
John Iredale
Edinburgh, Scotland
Patrick S. Kamath
Rochester, MN
Saul Karpen
Houston, TX
W. Ray Kim
Rochester, MN
Shelly C. Lu
Los Angeles, CA
Mark A. McNiven
Rochester, MN
Lopa Mishra
Washington, DC
David R. Nelson
Gainesville, FL
Vijay Shah
Rochester, MN
Gyongyi Szabo
Worchester, MA
C o n s u l t i n g B i o s t a t i s t i c i a n
Terry M. Therneau
Rochester, MN
H e p a t o l o g y E l s e w h e r e
Kris Kowdley
Seattle, WA
Geoffrey McCaughan
Newtown, Australia
Christian Trautwein
Aachen, Germany
E d i t o r s E m e r i t u s
Irwin M. Arias
Boston, MA, Founding Editor
Steven Schenker
San Antonio, TX
Paul D. Berk
New York, NY
D. Montgomery Bissell
San Francisco, CA
Andres T. Blei
Chicago, IL
I m a g e o f t h e M o n t h
M. Isabel Fiel
New York, NY
Thomas Schiano
New York, NY
P r o d u c t i o n S t a f f
Gregory Bologna
Managing Editor
Ann Tracy
Assistant Managing Editor
Kareytis Martinez
Editorial Assistant
Morgan Fincham
Editorial Assistant
Dawn Schultz
Editorial Assistant
E d i t o r i a l B o a r d
Gianfranco Alpini
Temple, TX
Paul Angulo
Lexington, KY
Gavin E. Arteel
Louisville, KY
Matias Avila
Pamplona, Spain
Matthias Bahr
Lubeck, Germany
Thomas F. Baumert
Strasbourg, France
Ulrich Beuers
Munich, Germany
Jorge Bezerra
Cincinnati, OH
Einar Bjornsson
Gothenburg, Sweden
Herbert L. Bonkovsky
Farmington, CT
Alastair D. Burt
Newcastle, UK
Roger F. Butterworth
Montreal, Canada
Naga Chalasani
Indianapolis, IN
Pei-Jer Chen
Taipei, Taiwan
John Chiang
Rootstown, OH
Helena Cortez-Pinto
Lisbon, Portugal
Jeffrey S. Crippin
St. Louis, MO
Nicholas O. Davidson
St. Louis, MO
Gary L. Davis
Dallas, TX
Angela Dolganiuc
Worcester, MA
Edward Doo
Bethesda, MD
Jean-Francois Dufour
Bern, Switzerland
Ariel Feldstein
Cleveland, OH
Peter Ferenci
Vienna, Austria
Francesco Feo
Sassari, Italy
Xavier Forns
Barcelona, Spain
Bin Gao
Bethesda, MD
Juan Carlos Garcia-Pagán
Barcelona, Spain
Guadalupe Garcia-Tsao
New Haven, CT
Jacob George
New South Wales, Australia
Pere Ginès
Barcelona, Spain
Ivo W. Graziadei
Innsbruck, Austria
Linda Greenbaum
Philadelphia, PA
Indra Neil Guha
Nottingham, United Kingdom
Steven-Huy B. Han
Los Angeles, CA
Stephen Harrison
Houston, TX
Hartmut Jaeschke
Kansas City, KS
David E. Kleiner
Bethesda, MD
Joel E. Lavine
San Diego, CA
Konstantinos Lazaridis
Rochester, MN
Josep M. Llovet
New York, NY
Velimir A.C. Luketic
Richmond, VA
Jacquelyn J. Maher
San Francisco, CA
Derek A. Mann
Newcastle, UK
Giulio Marchesini
Bologna, Italy
Jorge A. Marrero
Ann Arbor, MI
Jose M. Mato
Bizkaia, Spain
Vincenzo Mazzaferro
Milan, Italy
John G. McHutchison
Durham, NC
Satdarshan (Paul) Singh Monga
Pittsburgh, PA
Laura E. Nagy
Cleveland, OH
Michael H. Nathanson
New Haven, CT
Irene O.L. Ng
Hong Kong
John J. Poterucha
Rochester, MN
Vlad Ratziu
Paris, France
Barbara Rehermann
Bethesda, MD
Richard A. Rippe
Chapel Hill, NC
K. Lenhard Rudolph
Ulm, Germany
Sammy Saab
Los Angeles, CA
Arun J. Sanyal
Richmond, VA
Leonard B. Seeff
Bethesda, MD
Ekihiro Seki
La, Jolla, CA
Morris Sherman
Toronto, Canada
Kirti Shetty
Washington, DC
Benjamin Shneider
New York, NY
Kenneth J. Simpson
Edinburgh, UK
Ronald J. Sokol
Denver, CO
Richard K. Sterling
Richmond, VA
Jayant Talwalkar
Rochester MN
Brent A. Tetri
St. Louis, MO
Paul J. Thuluvath
Baltimore, MD
Mark Thursz
London, UK
Michael Torbenson
Baltimore, MD
Michael Trauner
Graz, Austria
Xin Wei Wang
Bethesda, MD
Xiao-Ming Yin
Pittsburgh, PA
Min You
Tampa, FL
Fabien Zoulim
Lyon, France
Jessica Zucman-Rossi
Paris, France
American Association for the Study of Liver Diseases-Governing Board 2010
P r e s i d e n t
Arun J. Sanyal
Richmond, VA
P r e s i d e n t - E l e c t
T. Jake Liang
Bethesda, MD
S e c r e t a r y
Jorge Bezerra
Cincinati, OH
T r e a s u r e r
Michael R. Lucey
Madison, WI
P a s t P r e s i d e n t
Scott L. Friedman
New York, NY
C o u n c i l o r s
Adrian M. Di Bisceglie
St. Louis, MO
J. Gregory Fitz
Dallas, TX
Guadalupe Garcia-Tsao
New Haven, CT
C o u n c i l o r s - a t - L a r g e
Ginny L. Bumgardner
Columbus, OH
Anna Mae Diehl
Durham, NH
Douglas R. LaBrecque
Iowa City, IA
P u b l i c a t i o n s C o m m i t t e e C h a i r
Michel B. Fallon
Houston, TX
|
